The non-canonical NF-kB pathway forms a major arm of NF-kB signalling that mediates important biological functions, including lymphoid organogenesis, B-lymphocyte function, and cell growth and survival 1-3 . Activation of the non-canonical NF-kB pathway involves degradation of an inhibitory protein, TNF receptor-associated factor 3 (TRAF3), but how this signalling event is controlled is still unknown 1,2 . Here we have identified the deubiquitinase OTUD7B as a pivotal regulator of the non-canonical NF-kB pathway. OTUD7B deficiency in mice has no appreciable effect on canonical NF-kB activation but causes hyperactivation of non-canonical NF-kB. In response to non-canonical NF-kB stimuli, OTUD7B binds and deubiquitinates TRAF3, thereby inhibiting TRAF3 proteolysis and preventing aberrant non-canonical NF-kB activation. Consequently, the OTUD7B deficiency results in B-cell hyper-responsiveness to antigens, lymphoid follicular hyperplasia in the intestinal mucosa, and elevated host-defence ability against an intestinal bacterial pathogen, Citrobacter rodentium. These findings establish OTUD7B as a crucial regulator of signal-induced non-canonical NF-kB activation and indicate a mechanism of immune regulation that involves OTUD7B-mediated deubiquitination and stabilization of TRAF3.
The non-canonical NF-kB pathway forms a major arm of NF-kB signalling that mediates important biological functions, including lymphoid organogenesis, B-lymphocyte function, and cell growth and survival [1] [2] [3] . Activation of the non-canonical NF-kB pathway involves degradation of an inhibitory protein, TNF receptor-associated factor 3 (TRAF3), but how this signalling event is controlled is still unknown 1,2 . Here we have identified the deubiquitinase OTUD7B as a pivotal regulator of the non-canonical NF-kB pathway. OTUD7B deficiency in mice has no appreciable effect on canonical NF-kB activation but causes hyperactivation of non-canonical NF-kB. In response to non-canonical NF-kB stimuli, OTUD7B binds and deubiquitinates TRAF3, thereby inhibiting TRAF3 proteolysis and preventing aberrant non-canonical NF-kB activation. Consequently, the OTUD7B deficiency results in B-cell hyper-responsiveness to antigens, lymphoid follicular hyperplasia in the intestinal mucosa, and elevated host-defence ability against an intestinal bacterial pathogen, Citrobacter rodentium. These findings establish OTUD7B as a crucial regulator of signal-induced non-canonical NF-kB activation and indicate a mechanism of immune regulation that involves OTUD7B-mediated deubiquitination and stabilization of TRAF3.
Unlike the canonical NF-kB pathway, which depends on degradation of IkBa, the non-canonical NF-kB pathway depends on the inducible processing of p100, a process that not only generates p52 but also leads to nuclear translocation of the p52-RelB dimer 2 . The processing of p100 is triggered through its phosphorylation by the NF-kB-inducing kinase (NIK) together with a downstream kinase, IkB kinase-a (IKK-a) 4, 5 . Steady-state non-canonical NF-kB activity is tightly controlled by TRAF3, which constantly targets NIK to the TRAF2-cIAPs E3 complex for degradation [6] [7] [8] . Activation of non-canonical NF-kB involves signal-induced TRAF3 proteolysis and NIK accumulation, but how this event is regulated is unknown 6 . The deubiquitinases (DUBs) CYLD and A20 are vital regulators of the canonical NF-kB pathway, but they are not involved in the regulation of non-canonical NF-kB signalling 9, 10 . Another DUB, OTUD7B (also called Cezanne), was identified on the basis of its sequence homology with A20 within their ovarian tumour (OTU) domains 11 . We studied the function of OTUD7B using Otud7b knockout (Otud7b 2/2 ) mice ( Supplementary Figs 1 and 2) . In contrast to the postnatal lethality of A20-deficient mice 12 , the Otud7b 2/2 mice did not show obvious defects in survival, although they had moderately reduced body weight ( Supplementary Fig. 3 ). The development of B and T cells appeared to be also normal in the Otud7b 2/2 mice (Supplementary Fig. 4 ). These phenotypes indicate fundamental differences in signalling function between OTUD7B and A20.
The OTUD7B deficiency had no appreciable effect on canonical NF-kB activation in mouse embryonic fibroblasts (MEFs), bone-marrowderived macrophages (BMDMs), or B cells ( Supplementary Fig. 5 ). Although OTUD7B has a related molecule, OTUD7A, OTUD7A was detected mainly in the central nervous system ( Supplementary  Fig. 6 ), arguing against the possibility of functional redundancies. We next examined the role of OTUD7B in regulating NF-kB activation by three well-characterized non-canonical NF-kB-stimulating receptors: lymphotoxin-b receptor (LTbR), CD40 and BAFF receptor (BAFFR) 1,2 . OTUD7B deficiency greatly enhanced NF-kB activation by agonistic anti-LTbR and anti-CD40 antibodies or BAFF ( Fig. 1a-c ), a result that was not due to differential expression of the receptors ( Supplementary Fig. 7 ). The heightened NF-kB DNA-binding activity in Otud7b 2/2 cells was associated with a marked increase in nuclear levels of p52 and RelB and concomitant loss of cytoplasmic p100 ( Fig. 1d-f ). However, OTUD7B deficiency did not promote the activation of canonical IKK or MAP kinases ( Supplementary Fig. 8 ), indicating a specific role for OTUD7B in non-canonical NF-kB regulation. We also found that OTUD7B expression was induced by the noncanonical NF-kB signals ( Supplementary Fig. 9 ), indicating a negative feedback function.
Compared with wild-type cells, Otud7b 2/2 cells displayed a markedly higher level of TRAF3 degradation and NIK accumulation in response to the non-canonical NF-kB inducers ( Fig. 2a, b and Supplementary Fig. 10 ). This effect was specific for the non-canonical NF-kB pathway, as OTUD7B deficiency did not alter the fate or function of TRAF3 in the type I interferon (IFN-I) pathway ( Supplementary  Figs 11 and 12) 13, 14 . The loss of OTUD7B promoted anti-CD40stimulated TRAF3 ubiquitination ( Fig. 2c ). Although the recombinant OTU domain of OTUD7B preferentially hydrolyses K11-linked ubiquitin chains in vitro 15 , we did not detect appreciable levels of K11 ubiquitination of TRAF3 ( Supplementary Fig. 13 ), which might be due to the quality of the anti-K11 ubiquitin antibody or the dominant K48 ubiquitination of TRAF3 (ref. 7) . However, K48 ubiquitination of TRAF3 was markedly enhanced in OTUD7B-deficient cells ( Fig. 2c ). Because OTUD7B also displays K48-specific DUB function in transfected cells 16 , it is conceivable that the specificity of OTUD7B may be regulated by cofactors in vivo, as implicated for A20 10 . The OTUD7Bmediated TRAF3 deubiquitination required its DUB activity, as a catalytically inactive OTUD7B mutant, C194S/H358R (CH), failed to deubiquitinate TRAF3 ( Fig. 2d, e ). Consistently, wild-type OTUD7B, but not OTUD7B(CH), suppressed the activation of non-canonical NF-kB signalling (Fig. 2f ). In response to CD40 or LTbR stimulation, OTUD7B was rapidly recruited to TRAF3 (Fig. 3a ), and this molecular interaction was coupled with the receptor recruitment of OTUD7B along with TRAF3, TRAF2 and c-IAP2 (Fig. 3b, c) . This finding was intriguing, because TRAF3 ubiquitination is mediated by c-IAP following their recruitment to the stimulating receptors 2, 7 . Although OTUD7B deficiency did not affect the recruitment of TRAF2, TRAF3 and c-IAP ( Fig. 3c ), TRAF3 MEFs were stimulated and subjected to identification of LTbR-associated proteins (upper) and analysis of protein expression (lower). d, Otud7b 2/2 MEFs, stably infected with wild-type OTUD7B or the indicated OTUD7B mutants, were stimulated with anti-LTbR and subjected to co-immunoprecipitation assays to detect OTUD7B-TRAF3 interaction (panel 1) and OTUD7B recruitment to LTbR (panel 2) or direct immunoblot assays (bottom two panels). Data are representative of two to three independent experiments.
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knockdown blocked the receptor recruitment of OTUD7B (Supplementary Fig. 14) . The ubiquitin-association (UBA) domain, but not the zinc finger (ZF) domain, of OTUD7B was required for its association with TRAF3 and receptor recruitment (Fig. 3d ). The UBA domain of OTUD7B was also indispensable for negatively regulating non-canonical NF-kB signalling ( Supplementary Fig. 15 ). These findings indicate that OTUD7B engages TRAF3 in response to cellular stimuli and, thereby, is recruited to the receptor complex, where it may mediate TRAF3 deubiquitination. Our finding that OTUD7B controls signal-induced, but not steadystate, activation of non-canonical NF-kB suggests specific roles for this DUB in the regulation of immune function. Otud7b 2/2 mice did not show obvious structural abnormalities of secondary lymphoid organs or the thymus, although the medullary thymic epithelial cells of Otud7b 2/2 mice had elevated expression of the autoimmune regulator (AIRE) and several other related genes, indicating a higher level of maturation (data not shown). Furthermore, Otud7b 2/2 mice displayed a remarkable phenotype in the mucosal tertiary lymphoid structures, characterized by a marked increase in the size and number of B-cell-containing colonic patches (CLPs) ( Fig. 4a and Supplementary   Fig. 16 ). Consistently, Otud7b 2/2 mice had a significant increase in faecal IgA concentration compared to wild-type mice (Fig. 4b ). Intestine is an organ that maintains dynamic host-microbiota homeostasis 17 , and unlike the secondary lymphoid organs, the development of which is programmed in the fetus, the formation and maintenance of intestinal tertiary lymphoid tissues occur in adults and involve microbial triggers and LTbR signalling [18] [19] [20] [21] . Indeed, injection of Otud7b 2/2 mice with a LTbR fusion protein (LTbR-Ig), known to block the interaction of LTbR with its ligands 18 , suppressed the lymphoid hyperplasia ( Fig. 4c and Supplementary Fig. 17 ). Consistent with the involvement of chemokines in LTbR-mediated induction of lymphoid follicles, the intestines of Otud7b 2/2 mice had elevated expression of two major chemokines, CXCL12 and CXCL13, and the cell adhesion molecule MADCAM1, which was suppressed upon injection of LTbR-Ig (Fig. 4d) . The LTbR-mediated induction of these genes was also enhanced in the Otud7b 2/2 MEFs (Fig. 4e) .
The results described above prompted us to examine whether OTUD7B negatively regulates mucosal immunity against infections. Indeed, the Otud7b 2/2 mice were considerably more resistant to a well-defined intestinal bacterial pathogen, C. rodentium 22 , as shown by 
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the significantly reduced bacterial load in organs and faeces and the ameliorated crypt hyperplasia in the colon ( Supplementary Fig. 18 ).
To compare the C. rodentium-induced lethality in the wild-type and Otud7b 2/2 mice, we took advantage of the recent finding that depletion of CD4 T cells in wild-type mice renders the mice sensitive to C. rodentium-induced lethality (Y.-X.F. et al., unpublished data). Under these conditions, all of the wild-type mice died of C. rodentium infection by day 14, whereas 75% of the Otud7b 2/2 mice survived infection (Fig. 4f ). Consistently, Otud7b 2/2 mice also experienced much milder body weight loss and had a significantly reduced faecal bacterial load compared to wild-type mice ( Fig. 4g and Supplementary Fig. 19 ). Collectively, these findings indicate the possibility that inhibition of OTUD7B may enhance mucosal immunity against C. rodentium infection.
Deregulated non-canonical NF-kB activation in B cells, as seen in B-cell-conditional Traf3 2/2 mice, is associated with B-cell hyperplasia and aberrant antibody production 23 . Consistently, OTUD7B-deficient B cells displayed elevated proliferative and survival ability when stimulated in vitro ( Fig. 4h and Supplementary Fig. 20) and were hyper-responsive to antigen-stimulated antibody production when adoptively transferred into Rag1 2/2 mice along with wild-type T cells ( Fig. 4i ). We found that Otud7b 2/2 mice did not show abnormal B-cell homeostasis under non-transferred conditions ( Supplementary Fig. 4 ). This was probably due to attenuated activation of the OTUD7Bdeficient T cells (data not shown), a phenotype that has also been observed with TRAF3-deficient T cells 24, 25 . Notably, upon injection with low doses of recombinant BAFF, the Otud7b 2/2 mice displayed overt B-cell hyperplasia (Fig. 4j) , coupled with accumulation of various antibody isotypes (Fig. 4k) , thus further indicating a negative role for OTUD7B in regulating B-cell responses.
Our findings establish OTUD7B as a pivotal negative regulator of the non-canonical NF-kB pathway. Although another DUB, DUBA, has been implicated in TRAF3 deubiquitination, DUBA regulates the K63 ubiquitination and non-degradative function of TRAF3 in the pattern-recognition receptor (PRR)-induced IFN-I signalling pathway 26 . So far, OTUD7B is the only DUB known to regulate TRAF3 degradation and non-canonical NF-kB signalling. OTUD7B is unique in that it specifically regulates signal-induced non-canonical NF-kB activation. These unique functions of OTUD7B make it an attractive candidate to be exploited as a therapeutic target to boost mucosal immunity and treat diseases associated with the non-canonical NF-kB pathway.
METHODS SUMMARY
Mice, infection and LTbR-Ig treatment. Otud7b 2/2 mice were generated by a conventional gene-targeting approach (Deltagen, Inc.) and backcrossed for four generations to the C57BL/6 background. Age-matched wild-type and Otud7b 2/2 mice were orally infected with C. rodentium and then killed for analyses of bacterial burdens and colon histology. In some experiments, the mice were depleted of CD4 T cells by injection of an anti-CD4 antibody before the C. rodentium infection. For assessing the role of LTbR signalling in colonic patch formation, the mice were injected intraperitoneally with PBS or LTbR-Ig on day 0 and day 5 and killed on day 10 for colon histology analyses. Cell culture and stimulation. HEK-293 cell culture and transfection, splenic B-cell purification, and the generation of BMDMs and MEFs were as described 27 . The cells were stimulated with the indicated inducers and subjected to cell proliferation or immunoblot assays. Statistical analysis. Two-tailed unpaired t-tests were performed using Prism software. P values less than 0.05 were considered significant, and the level of significance was indicated as *P , 0.05, **P , 0.01 and ***P , 0.001.
